247 related articles for article (PubMed ID: 7531416)
1. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C
Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-induced increase in the potential doubling time of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry.
Sarkaria JN; Gibson DF; Jordan VC; Fowler JF; Lindstrom MJ; Mulcahy RT
Cancer Res; 1993 Sep; 53(18):4413-7. PubMed ID: 8364937
[TBL] [Abstract][Full Text] [Related]
3. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
5. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME
Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304
[TBL] [Abstract][Full Text] [Related]
6. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
Strobl JS; Peterson VA
J Pharmacol Exp Ther; 1992 Oct; 263(1):186-93. PubMed ID: 1403784
[TBL] [Abstract][Full Text] [Related]
8. Measuring potential doubling times of murine tumors using flow cytometry.
Carlton JC; Terry NH; White RA
Cytometry; 1991; 12(7):645-50. PubMed ID: 1782833
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
Lykkesfeldt AE; Larsen JK; Christensen IJ
Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
[TBL] [Abstract][Full Text] [Related]
10. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.
Osborne CK; Boldt DH; Clark GM; Trent JM
Cancer Res; 1983 Aug; 43(8):3583-5. PubMed ID: 6861130
[TBL] [Abstract][Full Text] [Related]
11. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
Sutherland RL; Hall RE; Taylor IW
Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
[TBL] [Abstract][Full Text] [Related]
14. Tumour kinetics in breast cancer.
Winters Z; Mohube P; Gray C; Wright C; Teare J; Lange M; Mannell A; Myburgh JA
S Afr J Surg; 1994 Dec; 32(4):135-40. PubMed ID: 7597509
[TBL] [Abstract][Full Text] [Related]
15. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells.
Taylor IW; Hodson PJ; Green MD; Sutherland RL
Cancer Res; 1983 Sep; 43(9):4007-10. PubMed ID: 6871842
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle studies by multiparametric automatic scanning of topographically preserved cells in culture.
Colomb E; Kopp F; Spyratos F; Martin PM
Cytometry; 1989 May; 10(3):263-72. PubMed ID: 2714110
[TBL] [Abstract][Full Text] [Related]
17. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
18. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
19. S-phase arrest of nutrient deprived lung cancer cells.
Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
[TBL] [Abstract][Full Text] [Related]
20. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1995; 15(6B):2529-32. PubMed ID: 8669818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
